Nuvation Bio, Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
2.69
+0.10 (3.86%)
Aug 10, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Selling, General & Admin
|
24.28 | 10.95 | 6.99 |
| Research & Development
|
69.04 | 32.6 | 25.11 |
| Operating Expenses
|
93.32 | 43.55 | 32.1 |
| Operating Income
|
-93.32 | -43.55 | -32.1 |
| Interest Expense / Income
|
0 | 0 | 2.66 |
| Other Expense / Income
|
-6.47 | -1.89 | -1.21 |
| Pretax Income
|
-86.85 | -41.66 | -33.55 |
| Net Income
|
-86.85 | -41.66 | -33.55 |
| Net Income Common
|
-86.85 | -41.66 | -33.55 |
| Shares Outstanding (Basic)
|
198 | 98 | 207 |
| Shares Outstanding (Diluted)
|
198 | 98 | 207 |
| Shares Change
|
102.90% | -52.81% | - |
| EPS (Basic)
|
-0.44 | -0.43 | -0.16 |
| EPS (Diluted)
|
-0.44 | -0.43 | -0.16 |
| Free Cash Flow Per Share
|
-0.35 | -0.38 | -0.12 |
| EBITDA
|
-86.48 | -41.56 | -30.88 |
| Depreciation & Amortization
|
0.37 | 0.1 | 0.01 |
| EBIT
|
-86.85 | -41.66 | -30.89 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).